It is a fact that the European population growth is slowing down, while the population ageing accelerates. Rapid increases in the elderly population are predicted for the coming decades due to the ageing of post-war baby births. Within Europe’s ageing population, Hearing Loss, Cardio Vascular Diseases, Cognitive Impairments, Mental Health Issues and Balance Disorders, as well as Frailty, are prevalent conditions, with tremendous social and financial impact. Preventing, slowing the development of or dealing effectively with effects of the above impairments can have a significant impact on the quality of life and lead to significant savings in the cost of healthcare services. Digital tools hold the promise for many health benefits that can enhance the independent living and well-being of the elderly. Motivated by the above, the aim of the SMART BEAR platform is to integrate heterogeneous sensors, assistive medical and mobile devices to enable the continuous data collection from the everyday life of the elderly, which will be analysed to obtain the evidence needed in order to offer personalised interventions promoting their healthy and independent living. The platform will also be connected to hospital and other health care service systems to obtain data of the end users (e.g., medical history) that will need to be considered in making decisions for interventions. SMART BEAR will leverage big data analytics and learning capabilities, allowing for large scale analysis of the above mentioned collected data, to generate the evidence required for making decisions about personalised interventions. Privacy-preserving and secure by design data handling capabilities, covering data at rest, in processing, and in transit, will cover comprehensively all the components and connections utilized by the SMART BEAR platform. The SMART BEAR solution will be validated through five large-scale pilots involving 5.000 elderly living at home in Greece, Italy, France, Spain, and Romania.

In t-Clinic, a novel medical device will be validated as a new additional tool for early detection and prognosis of a number of pathologies: cancer, sepsis, stroke, diabetes, hypertension, infectious diseases, etc., and for different applications: epidemics, critical care, paediatrics, internal medicine, etc., that are based on subtle changes in the body temperature dynamics, not just in its absolute values (discover hidden information, bring to light undetected trends, find new diagnosis correlations). Body temperature quantification systems are currently the primary choice for standard clinical practice. However, due to the low sensitivity and specificity of these methods, a limited field of action, and null dynamics perspective, patients are often referred for secondary procedures, such as blood cultures, for more detailed diagnosis information. These referrals pose a global challenge that postpone treatment, increase the patient risks, and entail higher costs to the healthcare system (materials, labour requirements). There is a worldwide need to reduce the temporal and economic diagnosis costs to enable faster treatment of conditions and more affordable and sustainable healthcare systems by introducing preventive screenings and monitorings for earlier interventions. Innovatec has developed an advanced non-invasive body temperature monitor capable of long-term accurate thermoregulation assessment that can provide a low cost prompt diagnosis tool that will reduce the need for referrals, and will become an effective tool for body temperature dynamics correlation with disorder onset and progression. This is achieved by means of a precise multi-site body temperature monitoring scheme based on a portable wireless device, a set of clinical temperature probes (skin, tympanic, axillary, etc.), and a number of advanced signal entropy estimation algorithms developed by Innovatec's scientists in the last years, which are our most disruptive competitive advantage.